Dr. Plocken, earlier you testified that there are two happy vaccines in the market, one by Glaxo, GSK,

that's Ender XB and the other one is by Merck Recomba Vax HB, right?

Yes. This is the product the manufacturer insert for a Recomba Vax HB, correct?

Yes. And the clinical trial experience would be found in section 6.1, correct?

Correct?

Dr. Plocken. Yes.

Okay. In section 6.1, when you look at the clinical trials that were done pre-licensure for a Comba Vax HB,

how long does it say that safety was monitored after each dose?

Let's see.

Five days. Is five days long enough to detect an autoimmune issue that arises after five days?

No. Is five days long enough to detect any neurological disorder that arose from the vaccine after five days?

No. There is no control group, correct? It does not mention any control group, no.

No. If you turn to section 6.2, under immune system disorders, does it say that there were reports of hypersensitive reactions,

including anaphylactic, anaphylactoid reactions, bronchospasms, and udkariya having been reported within the first few hours after vaccination?

Yes.

They have been reports of hypersensitivity syndrome.

Yes. That is what it states.

Does it report of arthritis?

It is mentioned.

It also reports autoimmune diseases, including systemic lupus, erythematosis, lupus-like syndrome, vasculitis, and polytoritis, nidosa, as well, correct?

Yes. That is what it states.

And also, it states that under the nervous system disorders, it states that after that, there have been reports of Guillianborae syndrome, correct?

...